US5885567A
(en)
*
|
1993-10-22 |
1999-03-23 |
University Of Connecticut |
Treatment of infection in fowl by oral administration of avian interferon proteins
|
GB9700624D0
(en)
|
1997-01-14 |
1997-03-05 |
Danbiosyst Uk |
Drug delivery composition
|
CA2294988C
(en)
|
1997-07-01 |
2015-11-24 |
Isis Pharmaceuticals Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6423334B1
(en)
|
1997-10-01 |
2002-07-23 |
Elan Corporation, Plc |
Composition and method for enhancing transport across gastrointestinal tract cell layers
|
SE9703691D0
(sv)
*
|
1997-10-10 |
1997-10-10 |
Astra Ab |
Pharmaceutical compositions
|
FR2775188B1
(fr)
*
|
1998-02-23 |
2001-03-09 |
Lipha |
Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
JP2003524586A
(ja)
*
|
1998-05-21 |
2003-08-19 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
オリゴヌクレオチドの非−非経口投与のための組成物と方法
|
GB9824604D0
(en)
*
|
1998-11-11 |
1999-01-06 |
Hewlett Healthcare Limited |
Treatment of allergic conditions
|
WO2000033866A1
(en)
*
|
1998-12-04 |
2000-06-15 |
Provalis Uk Limited |
Pharmaceutical compositions containing insulin
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
US8119159B2
(en)
*
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
US7658938B2
(en)
*
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
AU2681300A
(en)
*
|
1999-02-22 |
2000-09-14 |
Elan Corporation, Plc |
Solid oral dosage form containing an enhancer
|
SE9901272D0
(sv)
*
|
1999-04-09 |
1999-04-09 |
Astra Ab |
New improved formulation
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
YU43702A
(sh)
*
|
1999-12-23 |
2004-11-25 |
Pfizer Products Inc. |
Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka
|
KR20010082721A
(ko)
*
|
2000-02-18 |
2001-08-30 |
고니시 진우에몬 |
지방산 함유 조성물
|
JP2001240558A
(ja)
*
|
2000-02-29 |
2001-09-04 |
Nippon Suisan Kaisha Ltd |
多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
|
CN1406131A
(zh)
*
|
2000-12-25 |
2003-03-26 |
株式会社资生堂 |
活化交感神经的香料组合物
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
KR20040018333A
(ko)
*
|
2001-02-16 |
2004-03-03 |
시미즈 세이야꾸 가부시키가이샤 |
소장 전달용 점액다당류 함유 경구 제형, 및 순환 장애치료에서의 이들의 용도
|
JP5026655B2
(ja)
*
|
2001-04-18 |
2012-09-12 |
プロメティック、バイオサイエンシーズ、インコーポレーテッド |
好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体
|
WO2002092070A1
(en)
*
|
2001-05-11 |
2002-11-21 |
Elan Corporation, Plc |
Isostearic acid salts as permeation enhancers
|
JP2004537516A
(ja)
*
|
2001-05-11 |
2004-12-16 |
オラセンス リミテッド |
アンチセンス浸透促進剤
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
AU2002330692A1
(en)
|
2001-07-02 |
2003-01-21 |
Elan Corporation, Plc. |
Delivery of a bioactive material
|
ES2539105T3
(es)
*
|
2001-07-06 |
2015-06-26 |
Asterias Biotherapeutics, Inc. |
Células mesenquimatosas y osteoblastos procedentes de células madre embrionarias humanas
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
DK1456380T3
(da)
*
|
2001-11-02 |
2012-07-30 |
Giuliani Int Ltd |
SMAD7-inhibitorer til behandling af CNS-sygdomme
|
MY139721A
(en)
*
|
2002-04-19 |
2009-10-30 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
GB0210397D0
(en)
*
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
KR100564021B1
(ko)
*
|
2002-12-11 |
2006-03-24 |
주식회사종근당 |
극성 약물의 경구용 약제학적 조성물
|
ES2255467T3
(es)
|
2003-02-07 |
2009-05-01 |
Prometic Biosciences Inc. |
Acidos grasos de cadena de longitud media, gliceridos y analogos como estimuladores de eritropoyesis.
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
PT1660047E
(pt)
|
2003-08-13 |
2014-02-27 |
Biocon Ltd |
Formulação de dosagem sólida de sais de ácidos gordos em micropartículas para agentes terapêuticos
|
KR20060109922A
(ko)
*
|
2003-10-31 |
2006-10-23 |
알자 코포레이션 |
가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형
|
WO2005089714A1
(ja)
*
|
2004-03-24 |
2005-09-29 |
Takeda Pharmaceutical Company Limited |
エマルション安定化製剤
|
MXPA06011871A
(es)
*
|
2004-04-15 |
2007-10-08 |
Chiasma Inc |
Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
|
US20070219131A1
(en)
*
|
2004-04-15 |
2007-09-20 |
Ben-Sasson Shmuel A |
Compositions capable of facilitating penetration across a biological barrier
|
US7645460B2
(en)
*
|
2004-05-24 |
2010-01-12 |
The Procter & Gamble Company |
Dosage forms of risedronate
|
US7645459B2
(en)
|
2004-05-24 |
2010-01-12 |
The Procter & Gamble Company |
Dosage forms of bisphosphonates
|
US20080287400A1
(en)
*
|
2004-05-24 |
2008-11-20 |
Richard John Dansereau |
Low Dosage Forms Of Risedronate Or Its Salts
|
US20080286359A1
(en)
*
|
2004-05-24 |
2008-11-20 |
Richard John Dansereau |
Low Dosage Forms Of Risedronate Or Its Salts
|
NZ553263A
(en)
|
2004-07-19 |
2010-06-25 |
Biocon Ltd |
Insulin-oligomer conjugates, formulations and uses thereof
|
WO2006022560A1
(en)
*
|
2004-08-23 |
2006-03-02 |
Auckland Uniservices Limited |
Gastric therapies and compositions therefor
|
MY139644A
(en)
*
|
2005-02-17 |
2009-10-30 |
Palm Nutraceuticals Sdn Bhd |
Improving the quality of crude oils and fats and recovery of minor components
|
CA2623678A1
(en)
*
|
2005-09-29 |
2007-04-05 |
Repros Therapeutics Inc. |
Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
|
ES2546016T3
(es)
*
|
2005-10-13 |
2015-09-17 |
Biocon Limited |
Procedimiento para la preparación de conjugados de insulina
|
US8920918B2
(en)
*
|
2005-10-31 |
2014-12-30 |
Kee Action Sports Technology Holdings, Llc |
Oil and polyethylene glycol fill material for use in paintball shells
|
US8846102B2
(en)
*
|
2006-03-30 |
2014-09-30 |
Engene, Inc. |
Non-viral compositions and methods for transfecting gut cells in vivo
|
EP2007397B1
(en)
*
|
2006-04-07 |
2013-07-24 |
Merrion Research III Limited |
Solid oral dosage form containing an enhancer
|
WO2007146234A2
(en)
*
|
2006-06-09 |
2007-12-21 |
Merrion Research Ii Limited |
Solid oral dosage form containing an enhancer
|
WO2009050738A2
(en)
*
|
2007-10-16 |
2009-04-23 |
Biocon Limited |
An orally administerable solid pharmaceutical composition and a process thereof
|
US20090271021A1
(en)
*
|
2008-04-28 |
2009-10-29 |
Popp Shane M |
Execution system for the monitoring and execution of insulin manufacture
|
TW200950799A
(en)
|
2008-05-07 |
2009-12-16 |
Merrion Res Iii Ltd |
Compositions of GnRH related compounds and processes of preparation
|
GB0808537D0
(en)
*
|
2008-05-12 |
2008-06-18 |
Archimedes Dev Ltd |
Compositions
|
US20100064927A1
(en)
*
|
2008-09-17 |
2010-03-18 |
Aldo Perrone |
Starch-based paintball fill material
|
WO2010032140A2
(en)
|
2008-09-17 |
2010-03-25 |
Chiasma Inc. |
Pharmaceutical compositions and related methods of delivery
|
AU2015201581B2
(en)
*
|
2008-09-17 |
2017-03-09 |
Amryt Endo, Inc. |
Pharmaceutical Compositions and Related Methods of Delivery
|
US20100215743A1
(en)
*
|
2009-02-25 |
2010-08-26 |
Leonard Thomas W |
Composition and drug delivery of bisphosphonates
|
PT3679941T
(pt)
|
2009-06-18 |
2022-11-10 |
Serenity Pharmaceuticals Llc |
Administração segura de desmopressina
|
EP2446189A1
(en)
|
2009-06-25 |
2012-05-02 |
Koninklijke Philips Electronics N.V. |
Heat managing device
|
EP3295935B1
(en)
|
2009-07-31 |
2020-07-22 |
Grünenthal GmbH |
Crystallization method and bioavailability
|
US20160016982A1
(en)
|
2009-07-31 |
2016-01-21 |
Thar Pharmaceuticals, Inc. |
Crystallization method and bioavailability
|
US9169279B2
(en)
|
2009-07-31 |
2015-10-27 |
Thar Pharmaceuticals, Inc. |
Crystallization method and bioavailability
|
AU2010339907A1
(en)
|
2009-12-16 |
2012-07-05 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
US20110142889A1
(en)
*
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
BR112012016853A2
(pt)
*
|
2010-01-12 |
2017-10-17 |
Novo Nordisk As |
"composições farmacêuticas para administração oral de peptídeos de insulina".
|
US20110182985A1
(en)
*
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
WO2011120033A1
(en)
*
|
2010-03-26 |
2011-09-29 |
Merrion Research Iii Limited |
Pharmaceutical compositions of selective factor xa inhibitors for oral administration
|
WO2012071517A2
(en)
|
2010-11-24 |
2012-05-31 |
Thar Pharmaceuticals, Inc. |
Novel crystalline forms
|
CA2819234A1
(en)
|
2011-01-07 |
2012-07-12 |
Merrion Research Iii Limited |
Pharmaceutical compositions of iron for oral administration
|
WO2016120378A1
(en)
|
2015-01-29 |
2016-08-04 |
Novo Nordisk A/S |
Tablets comprising glp-1 agonist and enteric coating
|
MA41462A
(fr)
|
2015-02-03 |
2021-05-12 |
Chiasma Inc |
Méthode de traitement de maladies
|
GB201511284D0
(en)
*
|
2015-06-26 |
2015-08-12 |
Univ Witwatersrand Jhb |
An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
|
WO2017208070A1
(en)
|
2016-05-31 |
2017-12-07 |
Grünenthal GmbH |
Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis
|
GB201904771D0
(en)
|
2019-04-04 |
2019-05-22 |
Orexo Ab |
New pharmaceutical compositions
|
GB201904767D0
(en)
|
2019-04-04 |
2019-05-22 |
Orexo Ab |
New pharmaceutical compositions
|
US11141457B1
(en)
|
2020-12-28 |
2021-10-12 |
Amryt Endo, Inc. |
Oral octreotide therapy and contraceptive methods
|
US11896719B2
(en)
|
2022-01-24 |
2024-02-13 |
Calliditas Therapeutics Ab |
Pharmaceutical compositions
|